acetylphenylalanyl-prolyl-boroarginine has been researched along with Phlegmasia Alba Dolens in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kettner, CA; Knabb, RM; Reilly, TM; Timmermans, PB | 1 |
1 other study(ies) available for acetylphenylalanyl-prolyl-boroarginine and Phlegmasia Alba Dolens
| Article | Year |
|---|---|
In vivo characterization of a new synthetic thrombin inhibitor.
Topics: Animals; Boron Compounds; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinolytic Agents; Male; Oligopeptides; Partial Thromboplastin Time; Prothrombin Time; Rabbits; Rats; Rats, Inbred Strains; Thrombin; Thrombin Time; Thrombophlebitis; Thrombosis | 1992 |